| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/02/2001 | WO2001055201A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055200A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055199A1 Peptide fragments of colostrinin and their use |
| 08/02/2001 | WO2001055198A2 Dermo- and gastro-specific sphingolipid activator |
| 08/02/2001 | WO2001055197A1 A novel polypeptide, human corticotropin-releasing factor 23(hcrf-23) and the polynucleotide encoding thereof |
| 08/02/2001 | WO2001055195A1 A novel polypeptide - human an1-like protein 16 and the polynucleotide encoding the same |
| 08/02/2001 | WO2001055193A1 A novel polypeptide-rna polymerase pb1 subunit 35 and the polynucleotide encoding the same |
| 08/02/2001 | WO2001055192A1 A novel polypeptide-human nerve growth factor 34 and the polynucleotide encoding the same |
| 08/02/2001 | WO2001055191A1 A novel polypeptide, transducin 18 and the polynucleotide encoding thereof |
| 08/02/2001 | WO2001055190A1 A novel polypeptide, d-isomer specific 2-hydroxy acid dehydrogenase 30 and the polynucleotide encoding thereof |
| 08/02/2001 | WO2001055189A1 A NOVEL POLYPEPTIDE, SECp43, 32 THAT ASSOCIATES SPECIFICALLY WITH HUMAN SELECNOCYSTEINE tRNA AND THE POLYNUCLEOTIDE ENCODING THEREOF |
| 08/02/2001 | WO2001055188A1 A new polypeptide-human zinc finger protein 46 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055187A1 A new polypeptide-zinc finger protein 49 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055186A1 A new polypeptide-human zinc finger protein 14 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055185A1 A new polypeptide-ribosome protein l20,16 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055184A1 A new polypeptide-human zinc finger protein 19 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055183A1 A novel polypeptide -- homo laminin protein 24 and polynucleotide encoding said polypeptide |
| 08/02/2001 | WO2001055182A1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA |
| 08/02/2001 | WO2001055179A2 Nucleic acids encoding polypeptides with homology to olfactory receptors |
| 08/02/2001 | WO2001055177A2 Methods to identify ctl epitopes of hiv |
| 08/02/2001 | WO2001055176A2 Methods for inhibiting smooth muscle cell proliferation |
| 08/02/2001 | WO2001055175A2 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 08/02/2001 | WO2001055174A2 Universal procedure for refolding recombinant proteins |
| 08/02/2001 | WO2001055173A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055172A2 ISOLATED COMPLEX COMPRISING A NNT-1 PROTEIN AND IN ADDITION AT LEAST A CLF-1 PROTEIN AND/OR A sCNTFRα PROTEIN |
| 08/02/2001 | WO2001055166A1 Cloned human lysophospholipase |
| 08/02/2001 | WO2001055165A1 A novel peptide---dna polymerase iii 12, polynucleotide coding this peptide and the method producing this peptide by dna recombination techniques |
| 08/02/2001 | WO2001055163A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055105A1 N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv |
| 08/02/2001 | WO2001054771A2 Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 08/02/2001 | WO2001054742A1 A medicinal aerosol formulation |
| 08/02/2001 | WO2001054741A1 A medicinal aerosol formulation |
| 08/02/2001 | WO2001054733A1 Nucleic acids, proteins and antibodies |
| 08/02/2001 | WO2001054729A1 Treatment of neuropsychiatric disease with protease and neuraminidase inhibitors |
| 08/02/2001 | WO2001054728A1 NOVEL REMEDIES WITH THE USE OF β3 AGONIST |
| 08/02/2001 | WO2001054722A1 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 08/02/2001 | WO2001054721A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases |
| 08/02/2001 | WO2001054715A1 Use of fsh for treating infertility |
| 08/02/2001 | WO2001054714A1 Method for regulating il-10 with il-9, and applications thereof |
| 08/02/2001 | WO2001054712A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 08/02/2001 | WO2001054711A2 Use of neurotoxins for treating diabetes |
| 08/02/2001 | WO2001054710A1 Auxiliary agents for ophthalmic operation |
| 08/02/2001 | WO2001054709A1 Vzv orf29p protein-related compositions and methods |
| 08/02/2001 | WO2001054708A1 22 human secreted proteins |
| 08/02/2001 | WO2001054706A2 Method for treating kidney disorders |
| 08/02/2001 | WO2001054694A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method |
| 08/02/2001 | WO2001054693A1 Use of thiostrepton as an anti-mycobacterial agent |
| 08/02/2001 | WO2001054690A1 Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses |
| 08/02/2001 | WO2001054686A2 L-arginine in combination with other compounds for treating cardiovascular diseases |
| 08/02/2001 | WO2001054681A2 Composition for treatment of stress |
| 08/02/2001 | WO2001054680A2 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 08/02/2001 | WO2001054664A1 A method of administering a medicinal aerosol formulation |
| 08/02/2001 | WO2001054659A2 Slimming cosmetic composition comprising a plant extract containing a plant natriuretic peptide (pnp) |
| 08/02/2001 | WO2001054651A2 Modulation of gene expression in formation of fatty atherosclerotic lesions |
| 08/02/2001 | WO2001054477A2 Novel nucleic acids and polypeptides |
| 08/02/2001 | WO2001054474A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001054473A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001054472A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001019854A3 Neurotransmitter transporter |
| 08/02/2001 | WO2001018550A3 Determination of adrenomedullin-binding proteins |
| 08/02/2001 | WO2001014548A3 New g-protein coupled receptor and dna sequences thereof |
| 08/02/2001 | WO2001013932A3 Stimulation of sperm function |
| 08/02/2001 | WO2001010386A3 Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof |
| 08/02/2001 | WO2001009327A3 Method of preventing the injury or death of retinal cells and treating ocular diseases |
| 08/02/2001 | WO2001007065A3 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 08/02/2001 | WO2001005826A3 Chimeric polypeptides of serum albumin and uses related thereto |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | WO2001004155A3 Feline interleukin-12 as an immune stimulant |
| 08/02/2001 | WO2001004146A3 Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof |
| 08/02/2001 | WO2001000828A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/02/2001 | WO2000070036A3 Genes expressed in hippocampus |
| 08/02/2001 | WO2000069898A3 Molecular interactions in allergy cells |
| 08/02/2001 | WO2000069887A3 Rapid dehydration of proteins |
| 08/02/2001 | WO2000066721A9 Decreasing adipose mass by altering rsk2 activity |
| 08/02/2001 | WO2000066175A3 Conjugates as therapies for cancer and prostate diseases |
| 08/02/2001 | WO2000065067A3 Prostate-specific polynucleotides, polypeptides and their methods of use |
| 08/02/2001 | WO2000064483A3 Releasable linkage and compositions containing same |
| 08/02/2001 | WO2000062790A8 Soluble tumor necrosis factor receptor treatment of medical disorders |
| 08/02/2001 | WO2000050580A3 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 08/02/2001 | WO2000050451A3 Protein (tp) that is involved in the development of the nervous system |
| 08/02/2001 | WO2000050063A3 Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction |
| 08/02/2001 | WO2000047625A3 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 08/02/2001 | WO2000046391A9 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 08/02/2001 | WO2000043514A9 Human acid sensing ion channel and uses thereof |
| 08/02/2001 | WO2000028996A9 Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides |
| 08/02/2001 | WO1999064587A8 Polypeptides with beta-secretase type activity |
| 08/02/2001 | WO1999049025A3 Human vault rna |
| 08/02/2001 | US20010011379 Mutant which interfers with virus reproduction during infection |
| 08/02/2001 | US20010011131 DNA molecules encoding cartilage-derived morphogenetic proteins |
| 08/02/2001 | US20010011127 Modulating activity of endogenous protein |
| 08/02/2001 | US20010011126 Isolated protein; genetic engineering |
| 08/02/2001 | US20010011124 Genetic engineering |
| 08/02/2001 | US20010011077 Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides |
| 08/02/2001 | US20010011073 Uses of transgenic animals containing a type X collagen mutant |
| 08/02/2001 | US20010011072 Skin disorders; kidney and liver disorders |
| 08/02/2001 | US20010011071 Polypeptide drug; antidiabetic agent |
| 08/02/2001 | US20010011070 Reduce concentration of phenylalanine in blood |
| 08/02/2001 | US20010010935 Useful in treating stem cells in a patient undergoing chemotherapy |
| 08/02/2001 | US20010010934 Polypeptides that regulate epithelial specific gene expression; hypoproliferative disorders; medical diagnosis |
| 08/02/2001 | US20010010933 Configuration; vectors; recombinants |